Single Molecule Real Time Sequencing Market Report 2026

The single molecule real time sequencing market size has grown strongly in recent years. It will grow from $3.43 billion in 2025 to $3.73 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to advancements in dna sequencing chemistry, expansion of genomic research programs, rising adoption of next-generation sequencing platforms, increased funding for genetic studies, growing use of long-read data in research.

The single molecule real time sequencing market size is expected to see strong growth in the next few years. It will grow to $5.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to rising demand for comprehensive genome analysis, increasing clinical adoption of long-read sequencing, expansion of epigenetics research applications, growing integration of ai-driven genomic analytics, continuous reduction in sequencing error rates. Major trends in the forecast period include increasing adoption of long-read sequencing technologies, rising demand for real-time dna analysis, growing integration of cloud-based bioinformatics tools, expansion of high-accuracy genome assembly applications, enhanced focus on structural variant detection.

The increasing prevalence of neurological diseases is expected to drive the growth of the single-molecule real-time sequencing market. Neurological diseases are conditions that impact the nervous system, including the brain, spinal cord, and peripheral nerves, resulting in a variety of symptoms such as impaired movement, sensation, cognition, and coordination. Common neurological disorders include Alzheimer's, Parkinson's, stroke, epilepsy, and others. The rise in neurological diseases can be linked to an aging population, greater awareness, enhanced diagnostic techniques, and environmental influences. Single-molecule real-time (SMRT) sequencing offers detailed genetic information that is essential for understanding and addressing neurological conditions. For example, in May 2024, a report by the Alzheimer's Association, a US-based nonprofit organization focused on Alzheimer’s support and research, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer’s increased from 6.5 million in 2022 to 6.9 million in 2024. Consequently, the growing prevalence of neurological diseases is expected to fuel the expansion of the single-molecule real-time sequencing market.

Key players in the single-molecule real-time sequencing market are concentrating on developing advanced solutions, such as benchtop long-read sequencers with high-fidelity read output, to strengthen their competitive position. A benchtop long-read sequencer is a compact laboratory instrument capable of producing long-read DNA sequences with high accuracy and moderate throughput, making advanced sequencing accessible beyond large genome centers. For instance, in November 2024, Pacific Biosciences, a US-based genomics firm, launched the Vega benchtop sequencer. It delivers up to 60 gigabases per run, generates highly accurate long reads (HiFi), and supports genomic, transcriptomic, and epigenetic data generation in small laboratories. These features expand the user base, accelerate adoption in research and clinical labs, and lower barriers to entry, although smaller labs may still encounter cost limitations for routine usage.

In July 2024, Inqaba Biotec, a biotechnology company based in South Africa, partnered with the University of South Africa (UNISA) to introduce Africa's first PacBio Revio sequencing platform, representing a major milestone in strengthening the continent's genomic research capabilities. The PacBio Revio platform is designed to advance research by allowing precise detection of DNA methylation patterns and offering deeper understanding of complex biological processes, such as gene regulation, development, and disease progression. The University of South Africa (UNISA) is a higher education institution in South Africa that provides a broad range of academic and vocational programs across multiple disciplines.

Major companies operating in the single molecule real time sequencing market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Pacific Biosciences of California Inc., Oxford Nanopore Technologies Limited, Illumina Inc., BGI Genomics Co. Ltd., Novogene Corporation, New England Biolabs Inc., Zymo Research Corporation, GENEWIZ Inc., Dovetail Genomics LLC, Singular Genomics Systems Inc., Horizon Discovery Group plc, Asuragen Inc., LGC Limited, Tecan Group Ltd, 10x Genomics Inc.

North America was the largest region in the single molecule real time sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single molecule real time sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single molecule real time sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the single molecule real time sequencing market by increasing costs of imported sequencing instruments, optical components, consumables, reagents, and data processing hardware. Genomics research centers and diagnostic laboratories in North America and Europe are most affected due to reliance on specialized imported systems, while Asia-Pacific faces increased equipment acquisition costs. These tariffs are raising capital investment requirements and slowing technology upgrades. However, they are also encouraging local assembly of sequencing instruments, regional reagent manufacturing, and domestic development of sequencing data analysis platforms.

The single molecule real time sequencing market research report is one of a series of new reports that provides single molecule real time sequencing market statistics, including single molecule real time sequencing industry global market size, regional shares, competitors with a single molecule real time sequencing market share, detailed single molecule real time sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the single molecule real time sequencing industry. This single molecule real time sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Single-molecule real-time (SMRT) sequencing is a DNA sequencing technology that directly monitors the synthesis of an individual DNA molecule in real-time, enabling long-read sequencing with high precision. This approach utilizes a zero-mode waveguide to detect nucleotide incorporation by a polymerase enzyme, delivering detailed and comprehensive genomic insights.

The primary stages of single-molecule real-time sequencing include pre-sequencing, sequencing, and data analysis. Pre-sequencing encompasses all processes that prepare samples for sequencing, such as DNA or RNA extraction, purification, and library preparation. The products are classified into consumables, instruments, and services for applications including DNA sequencing, RNA sequencing, epigenetics, whole genome sequencing, and others. The end users include hospitals, diagnostic laboratories, biopharmaceutical companies, academic institutions and research centers, among others.

The single molecule real time sequencing market consists of revenues earned by entities by providing services such as, consulting services, sequencing services, data analysis, training, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The single molecule real time sequencing market also includes sales of library preparation kits, repair kits, software, and data analysis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.